SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Enliven Therapeutics, Inc.
@ELVN_InsiderForm 4 Filing: Derynck Mika K Sells $11.3M of $ELVN
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Enliven Therapeutics, Inc.
Ticker: $ELVN
Transaction Value
$11.3M
Price/Share: $35.53
transaction date
2026-08-04
Shares: 317,590
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Derynck Mika K, holds the title of Director at Enliven Therapeutics, Inc..
On 2026-08-04, the insider transacted 317,590 shares.The shares were transacted at a weighted average price of $35.53 per share, resulting in a total market-relevant value of $11.3M.
Executive Summary Summary
Derynck Mika K (Director) sold $11.3M of $ELVN
Post-Transaction Position: 0 shares
SEC Accession No: 0001865125-26-000004 (CIK: 1865125)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.